3 Small-Cap Coronavirus Stocks That Could Skyrocket

3 Small-Cap Coronavirus Stocks That Could Skyrocket

There are many small biotechs developing experimental COVID-19 therapies and vaccine candidates. Arcturus' market cap now tops $1 billion. Arcturus announced in March that it was teaming up with Duke-NUS Medical School to develop a COVID-19 vaccine.